The transition from genetic to genome testing: the case of rare diseases

In this webinar, Dr. Francesc Palau, shares his experience of transitioning from genetic testing to genome testing. Watch this webinar to find out:

• How the adoption of Next Generation Sequencing (NGS) has the potential to change the rare disease landscape
• How a multi discipline team approach helps improve the understanding of rare diseases
• How whole genome sequencing could contribute to the future vision for rare disease

Speaker:

Francesc Palau, MD, PhD
Head, Dept. of Genetic and Molecular Medicine, and Director, Pediatric Institute for Rare Diseases (IPER)
Sant Joan de Déu Children’s Hospital and Research Institute, Barcelona, Spain.

CSIC Research Professor and Visiting Professor of Pediatrics
University of Barcelona School of Medicine. CIBERER’s Group Leader.